SCHEMBL5172265

SCHEMBL5172265

COc1cccc(C[C@@]2(Nc3cnc(/C=C/C(=O)O)cn3)CCNC2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 4/20 0.39
AKR1C2 P52895 3/20 0.39
CYP2D6 P10635 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
CA2 P00918 1/20 0.37
CA5A P35218 1/20 0.37
CA9 Q16790 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 3/20 0.35
PKM P14618 1/20 0.35
LMNA P02545 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5172609 0.92 GCK (0.42) AKR1C3KDM4EALDH1A1PKMSMN1; SMN2
SCHEMBL5197786 0.89 SLC6A2 (0.36) CYP2D6SLC6A2SLC6A4SLC6A3CA2
SCHEMBL5197021 0.88 AKR1C3 (0.34) AKR1C3AKR1C2CYP2D6SLC6A2SLC6A4
SCHEMBL5191421 0.87 HDAC3 (0.39) CYP2D6SLC6A2SLC6A4SLC6A3HDAC3
SCHEMBL5171686 0.87 SLC6A2 (0.35) AKR1C3AKR1C2CYP2D6SLC6A2SLC6A3
SCHEMBL5171643 0.86 HDAC4 (0.34) CYP2D6SLC6A2SLC6A4SLC6A3HDAC1
SCHEMBL5170203 0.86 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3LMNAHDAC4
SCHEMBL5168837 0.84 TYRO3 (0.36) CYP2D6ALDH1A1
SCHEMBL5170237 0.83 AKR1C3 (0.33) AKR1C3AKR1C2HDAC3HDAC1HDAC2
SCHEMBL5172054 0.82 TGFBR1 (0.35) CYP2D6SLC6A2SLC6A4SLC6A3HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776357-A1 HYDROXYAMIDE COMPOUNDS HAVING ACTIVITY AS INHIBITORS OF HISTONE DEACETYLASE (HDAC) Astellas Pharma Inc. (JP) 2007-04-25 EP disclosed
WO-2006016680-A1 HYDROXYAMIDE COMPOUNDS HAVING ACTIVITY AS INHIBITORS OF HISTONE DEACETYLASE (HDAC) ASTELLAS PHARMA INC. (JP) 2006-02-16 WO disclosed